Detail
| LncRNA Name | XIST |
| Synonyms | XIST, DXS1089, DXS399E, LINC00001, NCRNA00001, SXI1, swd66 |
| Region | GRCh38_X:73820651-73852753 Sequence |
| Ensembl | ENSG00000229807 |
| RefSeq | NR_001564 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | cervical cancer |
| ICD-0-3 | C53 |
| Methods | qPCR, Western blot, Luciferase reporter assay, etc. |
| Sample | cervical cancer tissues, cell lines (Hela, Caski, C4-1, Siha, GH329) |
| Expression Pattern | up-regulated |
| Function Description | XIST upregulated Fus through competitively binding with miR-200a. patients with high expression of XIST had a lower survival rate than those with low expression of XIST |
| Pubmed ID | 29909347 |
| Year | 2018 |
| Title | LncRNA XIST accelerates cervical cancer progression via upregulating Fus through competitively binding with miR-200a. |
| External Links |
| Links for XIST | GenBank HGNC lncrnadb Noncode |
| Links for cervical cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.